2Fank S,Kanpfer H,Wetzler C,et al.Large induction of the Chemotacfic cytokine RANTES experssion.Biochem J,2000,274(3):689-696. 被引量：1
3Wong CK,Ho CY,Li EK,et al.Elevation of proinflarnrnatory cytokine(IL-18,IL-17,IL-12)and Th2 cytokine(IL-4)concentrations in patients with systemic lupu serythematosus.Lupus,2000,9:589-593. 被引量：1
4Flisiak I,Klepacki A,Chodynicka B.Plasma and scales levels of interleukin-18 in comparison with other possible clinical and nlaboratory biomarkers of psoriasis activity.Biomarkers,2006,11:194-200. 被引量：1
5Pietrzak A,Janowski K,Chodorowska G,et al.Plasma interleukin-18 and dendritic cells in males with psoriasis vulgaris.Mediators lnflamm,2007,2007:61254. 被引量：1
二级参考文献8
1Kondo S, Yoneta A, Yazawa H, et al. Downregulation of CXCR- 2 but not CXCR- 1 expression by human keratinocytes by UVB. J Cell Physiol, 2000,182:366- 370. 被引量：1
2Vandenbark AA, Morgan E, Bartholomew R, et al. TCR peptide therapy in human autoimmune diseases. Neurochem Res, 2001,26:713- 730. 被引量：1
4Schroder JM, Harder J. Human beta- defensin- 2. Int J Biochem Cell Biol, 1999,31:645- 651. 被引量：1
5Nickoloff BJ. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T- cell- mediated skin disease. Viewpoint. J Cutan Pathol, 2001,28:57- 64. 被引量：1
6Hwang ST. Mechanisms of T cell homing to skin. Adv Dermatol, 2001,17:211- 241. 被引量：1
7Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol, 2002,46:1- 23. 被引量：1
8Aruffo A, Hollenbaugh D. Therapeutic intervention with inhibitors of co- stimulatory pathways in autoimmune disease. Curr Opin Immunol, 2001,13:683- 686. 被引量：1
